ID26730A - Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein - Google Patents

Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein

Info

Publication number
ID26730A
ID26730A IDW20002684A ID20002684A ID26730A ID 26730 A ID26730 A ID 26730A ID W20002684 A IDW20002684 A ID W20002684A ID 20002684 A ID20002684 A ID 20002684A ID 26730 A ID26730 A ID 26730A
Authority
ID
Indonesia
Prior art keywords
scd14
lait
proteins
induction
protein
Prior art date
Application number
IDW20002684A
Other languages
English (en)
Indonesian (id)
Inventor
Michael H Julius
Dominik Filipp
Original Assignee
Gemma Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gemma Biotechnology Ltd filed Critical Gemma Biotechnology Ltd
Publication of ID26730A publication Critical patent/ID26730A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596Molecules with a "CD"-designation not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IDW20002684A 1998-05-27 1999-05-27 Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein ID26730A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8688498P 1998-05-27 1998-05-27

Publications (1)

Publication Number Publication Date
ID26730A true ID26730A (id) 2001-02-01

Family

ID=22201526

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002684A ID26730A (id) 1998-05-27 1999-05-27 Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein

Country Status (14)

Country Link
US (1) US7592310B2 (cs)
EP (1) EP1080111B1 (cs)
JP (1) JP2002516339A (cs)
CN (1) CN1322214A (cs)
AU (1) AU771448B2 (cs)
BR (1) BR9910725A (cs)
CA (1) CA2328134A1 (cs)
CZ (1) CZ20004256A3 (cs)
HK (1) HK1041892A1 (cs)
HU (1) HUP0101987A3 (cs)
ID (1) ID26730A (cs)
IL (1) IL139339A0 (cs)
PL (1) PL345208A1 (cs)
WO (1) WO1999061468A2 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6474099A (en) * 1998-10-20 2000-05-08 Societe Des Produits Nestle S.A. Protein for treatment or prevention of a gi tract disorder
CA2404511A1 (en) * 2000-03-31 2001-10-04 Mochida Pharmaceutical Co., Ltd. Tlr/cd14 binding inhibitor
EP2266606B1 (en) 2003-05-15 2014-09-10 Genentech, Inc. Methods and compositions for the prevention and treatment of sepsis
ES2406266T3 (es) * 2004-05-11 2013-06-06 Mochida Pharmaceutical Co., Ltd. Antígeno CD14 soluble novedoso
WO2009095916A2 (en) * 2008-01-29 2009-08-06 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Cd14 and peptides thereof for protection of cells against cell death
ES2324192B1 (es) * 2008-01-30 2010-06-17 PUIG BEAUTY & FASHION GROUP, S.L. Derivados peptidicos utiles en el tratamiento, cuidado o limpieza de la piel, mucosa, cuero cabelludo o uñas.
CA2760096C (en) 2009-04-27 2018-10-30 Immuron Limited Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder.
WO2012023051A2 (en) * 2010-08-17 2012-02-23 Immuron Ltd. Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder
RU2723554C2 (ru) * 2011-05-19 2020-06-16 Мотида Фармасьютикал Ко., Лтд. Диагностика инфекционного заболевания дыхательных путей с использованием образцов крови

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543303A (en) 1988-11-28 1996-08-06 Goyert; Sanna M. Recombinant myelomonocytic differentiation antigen CD14
DK0485430T3 (da) 1989-08-01 1999-06-14 Scripps Research Inst Fremgangsmåder og sammensætninger til bedring af symptomer på sepsis
EP0634935A4 (en) * 1992-04-06 1996-01-31 North Shore Univ Hospital A NEW THERAPY OF SEPSIS BY MEANS OF A SOLUBLE FORM OF RECOMBINANT CD14 MYELOMONOCYTIC ANTIGEN.
US5820858A (en) 1993-05-28 1998-10-13 The Scripps Research Institute Methods and compositions for inhibiting CD14 mediated cell activation
US5932536A (en) 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
US5714469A (en) 1994-09-01 1998-02-03 Smithkline Beecham Corporation Method of treating sepsis
US5766593A (en) 1994-12-30 1998-06-16 Amgen Inc. Anti-inflammatory CD14 peptides
WO1996020957A1 (en) * 1994-12-30 1996-07-11 Amgen Inc. Anti-inflammatory cd14 polypeptides
WO1996032418A1 (en) 1995-04-13 1996-10-17 Laboratoires Om S.A. Anti-cd14 antibodies for use in the induction of il-10 secretion
PL185442B1 (pl) 1996-10-03 2003-05-30 Georgiades Biotech Ltd Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie
US6093693A (en) * 1996-11-18 2000-07-25 The Wellesley Hospital Foundation B cell activation
US6248329B1 (en) 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
WO1999061468A2 (en) 1999-12-02
JP2002516339A (ja) 2002-06-04
HK1041892A1 (zh) 2002-07-26
EP1080111B1 (en) 2012-07-25
HUP0101987A3 (en) 2010-01-28
US7592310B2 (en) 2009-09-22
CZ20004256A3 (cs) 2001-09-12
AU771448B2 (en) 2004-03-25
CN1322214A (zh) 2001-11-14
AU4025899A (en) 1999-12-13
BR9910725A (pt) 2001-01-30
EP1080111A2 (en) 2001-03-07
HUP0101987A2 (hu) 2001-09-28
IL139339A0 (en) 2001-11-25
WO1999061468A3 (en) 2000-04-06
PL345208A1 (en) 2001-12-03
CA2328134A1 (en) 1999-12-02
US20040259795A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
NO961796D0 (no) Rekombinante fedme (ob) proteiner
FI974429L (fi) Suspendoituja peptidi/proteiinivalmisteita
DE69434520D1 (de) Biotinylierung von proteinen
ATE458494T1 (de) Von der telomerase abgeleitete antigene peptide
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
NO983364L (no) Konsensusproteiner
FI965032A7 (fi) Interleukiini-5-spesifisiä yhdistelmä-vasta-aineita
DE69839603D1 (de) Zierenden proteins
DE69722620D1 (de) Nicht-waessrige protische peptidzubereitungen
FI962247L (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
FR2755627B1 (fr) Pipette multi-cylindre
DK0988861T3 (da) Stabiliserede proteinpræparater
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
ZA9811316B (en) Novel hepatitis C virus NS5B protein
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
NO983849D0 (no) Peptidderivater
ID26730A (id) Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein
NO971448D0 (no) Anti-Fas rekombinante antistoffer og DNA derfor
ID21034A (id) Protein kinase dan penggunaannya
FI961584A7 (fi) C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit
ID19257A (id) Protein-protein anti-obesitas
FI943218L (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt
ID26903A (id) Metode untuk menghasilkan protein terhidrolisis
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
FI980782A7 (fi) Epiteelisoluihin sitoutuva proteiinialue ja sitä koodaava DNA-sekvenssi